NDC 33342-106 – Emtricitabine and tenofovir disoproxil fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC33342-106

Product details

Brand name
Emtricitabine and tenofovir disoproxil fumarate
Generic name
Emtricitabine and tenofovir disoproxil fumarate
Labeler
Macleods Pharmaceuticals Limited
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA203442
Marketed since
May 15, 2020
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
33342-106-0730 TABLET, FILM COATED in 1 BOTTLE (33342-106-07)May 15, 2020

Other Emtricitabine and tenofovir disoproxil fumarate products